2012-02-08 14:02:04 -
COVINGTON, Ky., February 8, 2012 - Omnicare, Inc. (NYSE:OCR) today announced the
pilot launch of a new application for its cutting edge OmniviewDr platform. This
application allows prescribers, including physicians, nurse practitioners and
physician assistants to electronically transmit orders for controlled substance
prescriptions as well as other medications in real-time directly to Omnicare
pharmacies that service some of our nation's most frail and elderly citizens.
The new technology exponentially speeds up the time it takes for patients to
receive urgently needed medication while streamlining a cumbersome, manual,
paper-based process. Omnicare's proprietary technology solution will help
improve the quality
of pharmaceutical care for seniors and others in
institutional settings. Introduction of OmniviewDr will begin shortly,
culminating in a full market release by year end.
Omnicare developed the new OmniviewDr application to address the growing needs
of the physician and residents in Skilled Nursing Facilities (SNF), Assisted
Living (AL) communities, and Independent Living Facilities (ILF). Often times,
these patients are in pain or require access to medication that is essential to
their treatment. OmniviewDr will now be able to provide residents in
institutional settings with faster access to medication through cloud technology
that utilizes a unique two-factor authentication process to address important
safety and security regulations required for controlled substance prescriptions.
Importantly, physicians can access this functionality through their mobile
devices, further enhancing accessibility and communication with facilities.
Additionally, the OmniviewDr platform allows prescribers to:
* Review and respond to patient-specific comments posted by the Omnicare
consultant pharmacist;
* View SNF, AL and ILF patients' health records as prepared by Omnicare and
perform e-prescribing;
* Approve refills requests
* Request an estimated price quote for a specific drug;
* View a comprehensive document library
OmniviewDr is the physician-facing part of Omnicare's Omniview technology
portal, which offers a range of innovative cost-savings and health management
solutions for long-term care facilities, patients and caregivers. Omniview
capabilities include pre-admission medication assessment, e-refill, proof-of-
delivery, access to drug management reports, and real-time validation of Part D
coverage. Omnicare's investments in technology and automation have resulted in
greater accuracy, speed and consistency of service, which allow health care
providers to focus on direct care for those in need. Omnicare consistently
creates and implements new technologies designed to improve patient care and
increase efficiencies and reduce costs for the company and its customers.
Omnicare believes that its new OmniviewDr functionality fits directly within
these parameters.
"We are excited about this new OmniviewDr capability, which is consistent with
our goal to develop and implement innovative technologies that improve the
quality of care and create efficiencies for our customers, the physician
community, and for Omnicare," said Jeff Stamps, Executive Vice-President and
President, Long-Term Care Operations. "Our electronic controlled substance
prescribing process is the first product of its kind in the institutional
market. This forward thinking solution represents the future of prescribing
practices while simultaneously addressing patient needs quickly and in real
time. Importantly, it is also consistent with the country's mandate to improve
the quality of healthcare while reducing costs."
About Omnicare
Omnicare, Inc., a Fortune 400 company based in Covington, Kentucky, provides
comprehensive pharmaceutical services to patients and providers across North
America. As the market-leader in professional pharmacy, related consulting and
data management services for skilled nursing, assisted living and other chronic
care institutions, Omnicare leverages its unparalleled clinical insight into the
geriatric market along with some of the industry's most innovative technological
capabilities to the benefit of its long-term care customers. Omnicare also
provides key commercialization services for the bio-pharmaceutical industry and
end-of-life disease management through its Specialty Care Group. For more
information, visit www.omnicare.com.
# # #
Contacts:
Investors:
Patrick C. Lee
(859) 392-3444
patrick.lee@omnicare.com
Media:
Tim Canning
(859) 392-7444
tim.canning@omnicare.com
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Omnicare via Thomson Reuters ONE
[HUG#1583556]
